 In the majority of patients with morbid obesity, metabolic/bariatric<ORGANIZATION> surgery leads to relevant and sustained weight loss and improves obesity-related comorbidities, quality of life and functionality. Moreover, the associated reduction of risk factors for cardiovascular events and cancerous diseases has been shown to improve life expectations. Due<PERSON> to its excellent antidiabetic effect, the currently valid national S3 guidelines now recommend metabolic/bariatric surgery in patients who have a body mass index ( BMI<ORGANIZATION> ) â‰¥30 kg/m